Larry Robbins, CEO of Glenview Capital, departed the CVS Health board after joining in 2024. Robbins served on the Audit and Public Policy and External Affairs Committees during a period of transition for the company. His arrival came with a proposal to refresh corporate governance, improve operating performance, and restore financial discipline, he said. CEO David Joyner said Robbins helped sharpen the company's financial and operational focus and was instrumental in laying the foundation for future success.
This article was automatically created using artificial-intelligence technology and reviewed by Dow Jones Newswires editors.
At the request of the copyright holder, you need to log in to view this content
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.